Table 2 Basic and clinical characteristics of the AML patients in this study (n = 579)

Age at diagnosis, median (range)^a

Gender

 Male

 Female

WBC count at diagnosis (10⁹/L)^a

RBC count at diagnosis (10⁹/L)^a

Hemoglobin at diagnosis (g/L)^a

Platelets count at diagnosis (10⁹/L)^a

Neutrophil count at diagnosis (10⁹/L)^a

LDH at diagnosis (U/L)^a

Bone marrow blasts at diagnosis (%)^a

Peripheral blood blasts at diagnosis (%)^a

FBA subtype (n, %)

 M0

 M1

 M2

 M4

 M5

 M6

 M7

 Unknown

Allo-SCT (n, %)

 Yes

 No

Cytogenetics and molecular stratification

 Low risk (n, %)

 Intermediate risk (n, %)

 High risk (n, %)

 Unknown